Everything below concerns heptapeptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-06-22. Where a claim depends on a specific study, the study is described rather than over-claimed.
TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.
Thymosin beta-4 is a naturally occurring protein of 43 amino acids found in most mammalian cells, where it binds actin monomers and influences filament dynamics. It was first isolated from thymus tissue in the early 1980s, and its actin-binding activity was later mapped to a short region near the N-terminus. The synthetic fragment sold as TB-500 was designed to reproduce that region rather than the full protein. Whether a short fragment reproduces the behavior of the intact molecule remains an open question, since the parent protein carries additional structural elements outside the binding region.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
| Property | Value | Notes |
|---|---|---|
| Reported sequence | Ac-LKKTETQ | Described in most listings as the actin-binding region of thymosin beta-4 |
| Reported molecular weight | Approximately 889 Da | Value shifts with the stated sequence; compare against the certificate of analysis |
| Parent protein length | 43 amino acids | Thymosin beta-4; the fragment covers only a small part of it |
| Common synonyms | TB4 fragment; thymosin beta-4 fragment | Trade-style names rather than formal nomenclature |
| Formal monographs | Not established | Labeling conventions differ by supplier and region |
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
=== 1980s === In February 1981, the company announced a joint venture with Netherlands retail giant Vroom & Dreesmann, which gave its Dutch partner 50% buy-in to many of its retail stores. In 1987, Grace built a can sealant plant in Minhang, China, near Shanghai, becoming the first wholly foreign-owned, private company to do business in The People's Republic of China. In 1989, Grace sold Grace Equipment, an equipment rental company primarily for the petrochemical and construction industry to Companie Francaise de l'Afrique Occidentale (CFAO) of Paris for $305 million. In that same year, Grace did a public offering for 16.6% of its Grace Energy Corporation, which was a company that supplied services and equipment to the oil and gas industry and was involved in oil and gas exploration and development and coal mining as well. The public offering raised approximately $100 million.
The BBC reports that security is to be increased at Champions League games, following threats from a pro-IS media channel. Foreign Secretary David Cameron confirms that the UK will not suspend the sale of arms to Israel. The governor of the Bank of England, Andrew Bailey and chief cashier Sarah John, present King Charles III with his banknotes. 10 April A review into gender services carried out by paediatrician Dr Hilary Cass calls for gender services for young people to match the standards of other NHS care. Five people are arrested after pro-Palestinian protestors spray red paint on the Ministry of Defence building in London. Meta lowers the minimum age for WhatsApp users in the UK and EU from 16 to 13. 11 April The Victoria and Albert Museum and British Museum return a number of artefacts to Ghana on long-term loan, more than 150 years after they were taken. The Metropolitan Police says it will partly reinvestigate its decision to charge television presenter Caroline Flack with assaulting her boyfriend because "new witness evidence may be available". 12 April Data from the Office for National Statistics shows the UK economy grew by 0.1% in February, which is attributed to increases in production and manufacturing. The British government advises against all travel to Israel and Palestinian territories due to the imminent threat of an Iranian attack. 13 April Former subpostmaster Alan Bates says he will consider raising funds to bring a private prosecution against Post Office bosses over the Horizon IT scandal.
Nandrolone was probably among the first anabolic steroids to be used as a doping agent in sports in the 1960s. It has been banned at the Olympics since 1974. There are many known cases of doping in sports with nandrolone esters by professional athletes.
Sources: en.wikipedia.org
== History == An English group first purified AKH in 1976. The chemical structure was determined to be a peptide hormone formed from 10 amino acids. This was the first insect peptide hormone to be identified. After AKH was identified in cockroaches, locust AKH was inserted into a cockroach. A similar increase in lipid mobilization was observed. Conversely, cockroach AKH led to similar activity within a locust. AKH was initially discovered in the locusts Locusta migratoria and Schistocerca gregaria. It is generally associated with aiding flight. Lipids are transported from the hemolymph and metabolized by flight muscle in order to maintain flight. However, a high concentration of lipids remains in the hemolymph, implying that an agent may be responsible for activating lipid transport into the hemolymph. This was thought most likely to be a function of hormonal regulation. The hormone itself is part of a larger family, often referred to as red pigment concentrating hormones (RPCH) discovered in crustaceans. The consensus nomenclature is based on the name of the species in which the hormone was discovered and validated.
== Advisory roles and international engagement == Singh represented India on numerous national and international forestry bodies. He served as Chairman of the IX Commonwealth Forestry Conference in January 1968, where delegates recognized his effective moderation in revitalizing the conference's focus on global wood trends and economic forestry. His other international leadership roles included serving as Chairman of the Food and Agriculture Organization (FAO) Committee on Range Forest Management, Chairman of the Teak Sub-Commission, Chairman of the Technical Committee on Forestry and Forest Products (1965), and Vice-Chairman of the FAO Committee on Forest Development in the Tropics. He also participated in the Sixth World Forestry Congress in 1966. In 1970, following his retirement, the Government of India appointed him to the National Commission on Agriculture. Contributing heavily to the commission's 1976 report (Part IX on Forestry), Singh advocated for integrating forest management with agricultural objectives, emphasizing long-term ecological sustainability over the politically driven expansion of arable land.
It was first synthesized in 1540 by Valerius Cordus, who noted some of its medicinal properties. He called it oleum dulce vitrioli, a name that reflects the fact that it is synthesized by distilling a mixture of ethanol and sulfuric acid (known at that time as oil of vitriol). August Sigmund Frobenius gave the name Spiritus Vini Æthereus to the substance in 1730.
Sources: en.wikipedia.org
== Sources == This article incorporates text from a free content work. Licensed under CC BY 4.0 (license statement/permission). Text taken from World Food and Agriculture – Statistical Yearbook 2025, Food and Agriculture Organization of the United Nations. This article incorporates text from a free content work. Licensed under CC BY 4.0 (license statement/permission). Text taken from The State of Food Security and Nutrition in the World 2026, Food and Agriculture Organization of the United Nations.
==== British anti-Semitism ==== Although other factors played their part, historian Jonathan Schneer says that stereotypical thinking by British officials about Jews also played a role in the decision to issue the Declaration. Robert Cecil, Hugh O'Bierne and Sir Mark Sykes all held an unrealistic view of "world Jewry", the former writing "I do not think it is possible to exaggerate the international power of the Jews." Zionist representatives saw advantage in encouraging such views. James Renton concurs, writing that the British foreign policy elite, including Prime Minister David Lloyd George and Foreign Secretary A.J. Balfour, believed that Jews possessed real and significant power that could be of use to them in the war.
Early European alchemists gave sulfur an alchemical symbol of a triangle atop a cross (🜍). Another type of sulfur mentioned in alchemy, black sulfur (sulfur nigrum), also had its own symbol combining a two-barred cross atop a lemniscate (🜏). This symbol was later used by Anton LaVey as a satanist symbol, the "Leviathan cross", as he associated it with the brimstone of Hell. This has led to some confusion and misconceptions about its original alchemical meaning: in alchemical texts, black sulfur was not a synonym for "brimstone" or an alternative symbol for sulfur as one of the Three Primes, but was instead considered a distinct type of sulfur, listed separately. Black sulfur, also known as grey sulfur (sulfur griseum) or "horse brimstone" (sulfur caballinum), was a grey, impure form of sulfur, usually the dregs of sulfur purification, which was used for medicinal purposes despite often containing arsenic. Iron shavings or hammerscale were sometimes added to it in its manufacture. The "horse" in the name is thought to reference its veterinary use: low quality sulfur, only fit to treat horses. In the 19th century, it was sometimes also sold under the name "sulphur of ivy" (a corruption of sulfur vivum) and used on hops.
Chymotrypsinogen is an inactive precursor (zymogen) of chymotrypsin, a digestive enzyme which breaks proteins down into smaller peptides. Chymotrypsinogen is a single polypeptide chain consisting of 245 amino acid residues. It is synthesized in the acinar cells of the pancreas and stored inside membrane-bounded granules at the apex of the acinar cell. Release of the granules from the cell is stimulated by either a hormonal signal or a nerve impulse, and the granules spill into a duct leading into the duodenum.
Sources: en.wikipedia.org
Most listings describe it as a short acetylated peptide with the sequence Ac-LKKTETQ, presented as a region of thymosin beta-4. The label is a trade-style name rather than a standardized chemical name, so the exact content of a given vial depends on the supplier.
No. Thymosin beta-4 is a protein of 43 amino acids, while TB-500 is described as a short fragment of it. The two differ in size, structure, and the range of interactions each can support.
Naming for research peptides is not centrally coordinated, so vendors set their own labels and specifications. Differences in stated sequence, molecular weight, or purity documentation usually trace back to those independent labeling choices.
The leading proposal involves sequestration of monomeric actin, which would alter cytoskeletal turnover and cell movement. The actin-binding motif shared with the parent protein is central to that idea. Direct confirmation in whole organisms remains limited.